LR
Larry Robbins
Glenview Capital Management · Investor
1Y performance ⓘ
+26%
AUM (13F)
$4.0B
# of Holdings
43
3Y performance ⓘ
+57%
vs S&P 500 ⓘ
−22%
Updated
Mar 31
Larry Robbins's Glenview Capital Management holds 43 U.S.-equity positions worth $4.0B (SEC 13F, Q1 2026). Top positions: CVS HEALTH CORPORATION 14.8%, Global Payments, Inc. 10.9%, Tenet Healthcare Corporation New 7.2%. 13F-replication return is +57% over 3 years (-22 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| CVS CVS HEALTH CORPORATION | 14.8% | 8.2M | $589M | — | $62.84 | $85.50 (+36%) | 2026-03-31 |
| GPN CALL Global Payments, Inc. | 10.9% | 6.5M | $435M | ▲ 9.1% CALL (+539K) | — | — | 2026-03-31 |
| THC Tenet Healthcare Corporation New | 7.2% | 1.5M | $288M | ▼ 23% (−459K) | $76.96 | $259.15 (+237%) | 2026-03-31 |
| AMZN Amazon.Com Inc | 5.5% | 1.1M | $221M | ▲ 16% (+150K) | $193.35 | $249.66 (+29%) | 2026-03-31 |
| TEVA Teva Pharmaceutical Inds Ltd | 5.0% | 6.7M | $201M | ▼ 60% (−10.1M) | $14.97 | $39.24 (+162%) | 2026-03-31 |
| QQQ CALL Invesco Qqq Tr | 4.8% | 328K | $189M | NEW CALL (+328K) | — | — | 2026-03-31 |
| CI The Cigna Group | 3.3% | 499K | $133M | ▲ 79% (+219K) | $269.32 | $269.79 (+0%) | 2026-03-31 |
| AMD Advanced Micro Devices | 3.3% | 651K | $132M | ▲ 65% (+257K) | $209.93 | $616.58 (+194%) | 2026-03-31 |
| TMO Thermo Fisher Scientific, Inc. | 3.1% | 251K | $123M | ▲ 12% (+27K) | $460.57 | $670.23 (+46%) | 2026-03-31 |
| VTRS Viatris Inc. Common Stock | 3.1% | 9.1M | $123M | ▼ 18% (−2.0M) | $11.52 | $17.77 (+54%) | 2026-03-31 |
| DXC DXC Technology Company | 2.8% | 8.9M | $112M | ▲ 7.0% (+580K) | $20.40 | $11.71 (−43%) | 2026-03-31 |
| CNC Centene Corporation | 2.6% | 3.2M | $105M | ▲ 73% (+1.4M) | $40.50 | $61.74 (+52%) | 2026-03-31 |
| UBER Uber Technologies, Inc. | 2.6% | 1.5M | $105M | ▲ 106% (+748K) | $71.92 | $68.34 (−5%) | 2026-03-31 |
| GTM ZoomInfo Technologies Inc Common Stock | 2.4% | 15.9M | $95M | ▼ 20% (−4.1M) | $10.21 | $3.90 (−62%) | 2026-03-31 |
| IWM PUT Ishares Tr | 2.3% | 375K | $93M | NEW PUT (+375K) | — | — | 2026-03-31 |
| XYZ Block, Inc. | 2.1% | 1.4M | $82M | ▲ 60% (+513K) | $64.94 | $73.64 (+13%) | 2026-03-31 |
| META Meta Platforms, Inc. Class A Common Stock | 1.8% | 123K | $70M | ▲ 960% (+111K) | $572.99 | $732.25 (+28%) | 2026-03-31 |
| AMAT Applied Materials Inc | 1.7% | 197K | $67M | ▲ 52% (+68K) | $286.04 | $528.75 (+85%) | 2026-03-31 |
| ONTO Onto Innovation Inc. | 1.5% | 300K | $61M | ▼ 28% (−115K) | $139.18 | $314.08 (+126%) | 2026-03-31 |
| DKS Dick's Sporting Goods, Inc. | 1.5% | 299K | $59M | ▲ 5.3% (+15K) | $201.86 | $133.72 (−34%) | 2026-03-31 |
| HUM Humana Inc. | 1.5% | 335K | $58M | NEW (+335K) | $173.39 | $382.89 (+121%) | 2026-03-31 |
| BFLY Butterfly Network, Inc. | 1.4% | 14.3M | $58M | — | $2.45 | $8.79 (+259%) | 2026-03-31 |
| ESI Element Solutions Inc. | 1.4% | 1.6M | $56M | ▼ 43% (−1.2M) | $23.33 | $36.12 (+55%) | 2026-03-31 |
| UAL United Airlines Holdings, Inc. Common Stock | 1.1% | 497K | $46M | ▼ 2.8% (−14K) | $74.17 | $110.17 (+49%) | 2026-03-31 |
| EYE National Vision Holdings, Inc. Common Stock | 1.0% | 1.6M | $41M | ▲ 9.6% (+137K) | $25.59 | $16.52 (−35%) | 2026-03-31 |
| FUN Six Flags Entertainment Corporation | 1.0% | 2.2M | $39M | ▲ 98% (+1.1M) | $16.53 | $10.74 (−35%) | 2026-03-31 |
| GENI Genius Sports Limited | 0.9% | 8.6M | $38M | ▲ 322% (+6.5M) | $5.99 | $5.68 (−5%) | 2026-03-31 |
| USFD US Foods Holding Corp. | 0.9% | 384K | $35M | ▼ 66% (−754K) | $44.99 | $91.72 (+104%) | 2026-03-31 |
| Z Zillow Group, Inc. Class C Capital Stock | 0.8% | 790K | $33M | ▼ 32% (−374K) | $74.97 | $27.39 (−63%) | 2026-03-31 |
| LAD Lithia Motors, Inc. | 0.8% | 128K | $32M | — | $322.85 | $290.11 (−10%) | 2026-03-31 |
| BLCO Bausch + Lomb Corporation | 0.8% | 1.9M | $30M | ▲ 16% (+257K) | $14.00 | $17.08 (+22%) | 2026-03-31 |
| DHR Danaher Corporation | 0.7% | 156K | $30M | ▼ 22% (−44K) | $198.12 | $219.82 (+11%) | 2026-03-31 |
| LION Lionsgate Studios Corp. | 0.7% | 2.8M | $27M | ▼ 63% (−4.7M) | $7.64 | $11.06 (+45%) | 2026-03-31 |
| CSCO Cisco Systems, Inc. Common Stock (DE) | 0.7% | 340K | $26M | NEW (+340K) | $77.59 | $107.28 (+38%) | 2026-03-31 |
| MYGN Myriad Genetics Inc | 0.6% | 5.4M | $24M | ▲ 18% (+825K) | $13.06 | $4.28 (−67%) | 2026-03-31 |
| SGRY Surgery Partners, Inc. Common Stock | 0.5% | 1.8M | $21M | ▼ 53% (−2.1M) | $19.77 | $13.90 (−30%) | 2026-03-31 |
| DOCN DigitalOcean Holdings, Inc. | 0.5% | 250K | $21M | ▼ 88% (−1.8M) | $48.12 | $133.29 (+177%) | 2026-03-31 |
| BKR Baker Hughes Company | 0.5% | 304K | $19M | NEW (+304K) | $61.05 | $55.03 (−10%) | 2026-03-31 |
| AKAM Akamai Technologies Inc | 0.5% | 156K | $18M | NEW (+156K) | $114.85 | $105.95 (−8%) | 2026-03-31 |
| INTC Intel Corp | 0.4% | 400K | $18M | NEW (+400K) | $36.74 | $119.69 (+226%) | 2026-03-31 |
| BIIB Biogen Inc. Common Stock | 0.3% | 57K | $10M | ▼ 80% (−234K) | $175.99 | $225.46 (+28%) | 2026-03-31 |
| PRMB Primo Brands Corporation | 0.2% | 531K | $10M | NEW (+531K) | $18.83 | $19.02 (+1%) | 2026-03-31 |
| TECH Bio-Techne Corp. | 0.2% | 186K | $10M | ▼ 70% (−434K) | $56.89 | $72.42 (+27%) | 2026-03-31 |
FAQ ▾
What are Larry Robbins's largest holdings?
As of the latest 13F: CVS HEALTH CORPORATION 14.8%, Global Payments, Inc. 10.9%, Tenet Healthcare Corporation New 7.2%, Amazon.Com Inc 5.5%, Teva Pharmaceutical Inds Ltd 5.0%.
How big is Glenview Capital Management's 13F portfolio?
$4.0B across 43 disclosed U.S.-equity positions.
What is Larry Robbins's 3-year performance?
+57% (13F-replication, price return), -22 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.